LONDON, July 10 (Reuters) - Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents, in ...

US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million pound battle against US rival Moderna over the COVID-19 vaccine. The Appeals ...

German-based biotech company BioNTech SE is set to acquire InstaDeep, a Tunis-born and U.K.-based artificial intelligence (AI) startup, for up to £562 million (~$680 million) in its largest deal yet.

German vaccine maker BioNTech SE (NASDAQ:BNTX) revealed on May 20 that it intends to boost its presence in the UK with an investment of up to £1 billion ($1.33 billion) over the next decade, focusing ...

German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday. Up to ...

BERLIN, Feb 19 (Reuters) - Clinical trials for BioNTech's (22UAy.DE), opens new tab cancer vaccines should start this year in Britain, marking an important step towards their possible sale on the open ...

In a nutshell: Starting this September in England, BioNTech, the German company that developed one of the most widely used Covid-19 vaccines alongside Pfizer, will begin clinical trials of ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The new logo of German biotech firm BioNTech is seen outside the company's headquarters in Mainz (Reuters) - BioNTech ...